SCHEMBL20277045

SCHEMBL20277045

Cc1ccccc1N1c2c(ccc3c2Cc2ccccc2-3)N(C)[C@@H]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ CASP6 P55212 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ PGR P06401 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ PNMT P11086 1/20 0.33
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20276919 0.90 KMT2A (0.40) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20276740 0.85 KMT2A (0.39) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20276912 0.84 KMT2A (0.38) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20276739 0.84 KMT2A (0.39) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20277095 0.82 KMT2A (0.39) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20276973 0.81 KDM4E (0.30) ALDH1A1HPGDKDM4E
SCHEMBL20276744 0.79 KMT2A (0.38) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20276920 0.79 KMT2A (0.38) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20276970 0.77 KMT2A (0.40) KMT2ATDP1CASP3CASP6SENP8
SCHEMBL20277046 0.77 KMT2A (0.40) KMT2ATDP1CASP3CASP6SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180175308-A1 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180175308-A1 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OSBP KMT2A 4058/4885TDP1 2109/4885CASP3 2123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback